1. Home
  2. IQV vs GFS Comparison

IQV vs GFS Comparison

Compare IQV & GFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$238.70

Market Cap

35.1B

Sector

Health Care

ML Signal

HOLD

Logo GlobalFoundries Inc.

GFS

GlobalFoundries Inc.

HOLD

Current Price

$53.93

Market Cap

37.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IQV
GFS
Founded
1982
2009
Country
United States
United States
Employees
93000
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
35.1B
37.8B
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
IQV
GFS
Price
$238.70
$53.93
Analyst Decision
Strong Buy
Buy
Analyst Count
16
12
Target Price
$227.13
$45.08
AVG Volume (30 Days)
1.4M
4.0M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
4.67
N/A
EPS
1.61
N/A
Revenue
$9,739,000,000.00
N/A
Revenue This Year
$6.77
$7.64
Revenue Next Year
$5.89
$9.90
P/E Ratio
$144.37
$29.28
Revenue Growth
41.60
N/A
52 Week Low
$154.50
$31.51
52 Week High
$251.36
$92.55

Technical Indicators

Market Signals
Indicator
IQV
GFS
Relative Strength Index (RSI) 62.34 33.24
Support Level $218.57 $45.80
Resistance Level $247.52 $90.61
Average True Range (ATR) 7.83 2.95
MACD 0.63 0.15
Stochastic Oscillator 64.79 24.11

Price Performance

Historical Comparison
IQV
GFS

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

About GFS GlobalFoundries Inc.

GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates, which remains its controlling shareholder today. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and has about 13,000 staff.

Share on Social Networks: